National Cancer Institute; Notice of Closed Meetings, 23805 [2015-09875]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 82 / Wednesday, April 29, 2015 / Notices
Dated: April 23, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–09877 Filed 4–28–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications/
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications/
contract proposals, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Prevent
ToxPharm.
Date: May 19, 2015.
Time: 10:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
2W914, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Thomas M. Vollberg,
Ph.D., Chief, Scientific Review Officer,
Research Technology and Contract Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W102, Rockville, MD
20850, 240–276–6341, vollbert@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Novel
Imaging Agents to Expand the Clinical
Toolkit for Cancer Diagnosis, Staging and
Treatment.
Date: May 20, 2015.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
1E030, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Kenneth L. Bielat, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
VerDate Sep<11>2014
17:18 Apr 28, 2015
Jkt 235001
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W244, Rockville, MD 20850,
240–276–6373, bielatk@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Prevent
Bioefficacy/Intermediate Endpoints.
Date: May 28, 2015.
Time: 10:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
2W914, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Thomas M. Vollberg,
Ph.D., Chief, Scientific Review Officer,
Research Technology and Contract Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W102, Rockville, MD
20850, 240–276–6341, vollbert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Tumor
Tissue Culture Systems.
Date: June 23, 2015.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposal.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
6W030, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Nicholas J. Kenney, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W246, Rockville, MD 20850,
240–276–6374, nicholas.kenney@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Omnibus
SEP–16.
Date: July 15, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
6W032, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Majed M. Hamawy, Ph.D.,
MBA, Scientific Review Officer, Research
Program Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W120, Rockville, MD 20850, 240–
276–6457, mh101v@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
PO 00000
Frm 00045
Fmt 4703
Sfmt 9990
23805
Dated: April 23, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–09875 Filed 4–28–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Contract Grant Review.
Date: May 5, 2015.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Ernest Lyons, Ph.D.,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS/Neuroscience
Center, 6001 Executive Boulevard, Suite
3208, MSC 9529, Bethesda, MD 20892–9529,
301–496–4056,lyonse@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: April 23, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–09876 Filed 4–28–15; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\29APN1.SGM
29APN1
]]>Agencies
[Federal Register Volume 80, Number 82 (Wednesday, April 29, 2015)]
[Notices]
[Page 23805]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-09875]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications/contract proposals and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications/contract
proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Prevent ToxPharm.
Date: May 19, 2015.
Time: 10:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 2W914, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Thomas M. Vollberg, Ph.D., Chief, Scientific
Review Officer, Research Technology and Contract Review Branch,
Division of Extramural Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W102, Rockville, MD 20850, 240-276-
6341, vollbert@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Novel Imaging Agents to Expand the Clinical Toolkit for
Cancer Diagnosis, Staging and Treatment.
Date: May 20, 2015.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 1E030, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W244, Rockville, MD 20850, 240-276-6373,
bielatk@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Prevent Bioefficacy/Intermediate Endpoints.
Date: May 28, 2015.
Time: 10:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 2W914, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Thomas M. Vollberg, Ph.D., Chief, Scientific
Review Officer, Research Technology and Contract Review Branch,
Division of Extramural Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W102, Rockville, MD 20850, 240-276-
6341, vollbert@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Tumor Tissue Culture Systems.
Date: June 23, 2015.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposal.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 6W030, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Nicholas J. Kenney, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W246, Rockville, MD 20850, 240-276-6374,
nicholas.kenney@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Omnibus SEP-16.
Date: July 15, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 6W032, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Majed M. Hamawy, Ph.D., MBA, Scientific Review
Officer, Research Program Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W120, Rockville, MD 20850, 240-276-6457,
mh101v@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: April 23, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-09875 Filed 4-28-15; 8:45 am]
BILLING CODE 4140-01-P
